148 related articles for article (PubMed ID: 34288191)
1. Small cell lung cancer treatment and survival in Portugal: A retrospective analysis from the I-O Optimise initiative.
Soares M; Antunes L; Redondo P; Borges M; Grimson F; Hermans R; Chaib C; Lacoin L; Juarez-Garcia A; Daumont MJ; Penrod JR; Bento MJ; Gonçalves FR
Eur J Cancer Care (Engl); 2021 Nov; 30(6):e13496. PubMed ID: 34288191
[TBL] [Abstract][Full Text] [Related]
2. Real-world treatment patterns and survival outcomes for advanced non-small cell lung cancer in the pre-immunotherapy era in Portugal: a retrospective analysis from the I-O Optimise initiative.
Soares M; Antunes L; Redondo P; Borges M; Hermans R; Patel D; Grimson F; Munro R; Chaib C; Lacoin L; Daumont M; Penrod JR; O'Donnell JC; Bento MJ; Rocha Gonçalves F
BMC Pulm Med; 2020 Sep; 20(1):240. PubMed ID: 32912174
[TBL] [Abstract][Full Text] [Related]
3. Treatment patterns and outcomes among patients with small-cell lung cancer (SCLC) in Europe: a retrospective cohort study.
Blackhall F; Girard N; Livartowski A; McDonald L; Roset M; Lara N; Juarez García A
BMJ Open; 2023 Feb; 13(2):e052556. PubMed ID: 36746549
[TBL] [Abstract][Full Text] [Related]
4. Outcomes of small cell lung cancer patients treated with cisplatin-etoposide versus carboplatin-etoposide.
Karam I; Jiang SY; Khaira M; Lee CW; Schellenberg D
Am J Clin Oncol; 2015 Feb; 38(1):51-4. PubMed ID: 23563211
[TBL] [Abstract][Full Text] [Related]
5. Treatment patterns and survival outcomes for small-cell lung cancer patients - a Swedish single center cohort study.
Tendler S; Zhan Y; Pettersson A; Lewensohn R; Viktorsson K; Fang F; De Petris L
Acta Oncol; 2020 Apr; 59(4):388-394. PubMed ID: 31910696
[No Abstract] [Full Text] [Related]
6. Factors associated with overall survival, progression-free survival and toxicity in patients with small cell lung cancer and thoracic irradiation in a clinical real-world setting.
Kassik MT; Vordermark D; Kornhuber C; Medenwald D
Radiat Oncol; 2023 Apr; 18(1):70. PubMed ID: 37072833
[TBL] [Abstract][Full Text] [Related]
7. Real-world treatment patterns and outcomes of patients with small cell lung cancer progressing after 2 lines of therapy.
Coutinho AD; Shah M; Lunacsek OE; Eaddy M; Willey JP
Lung Cancer; 2019 Jan; 127():53-58. PubMed ID: 30642551
[TBL] [Abstract][Full Text] [Related]
8. Real-world treatment patterns and outcomes of patients with extensive disease small cell lung cancer.
Cramer-van der Welle CM; Schramel FMNH; van Leeuwen AS; Groen HJM; van de Garde EMW;
Eur J Cancer Care (Engl); 2020 Sep; 29(5):e13250. PubMed ID: 32406593
[TBL] [Abstract][Full Text] [Related]
9. Standard- and high-dose etoposide, ifosfamide, carboplatin, and epirubicin in 100 patients with small-cell lung cancer: a mature follow-up report.
Fetscher S; Brugger W; Engelhardt R; Kanz L; Hasse J; Frommhold H; Lange W; Mertelsmann R
Ann Oncol; 1999 May; 10(5):561-7. PubMed ID: 10416006
[TBL] [Abstract][Full Text] [Related]
10. A systematic review of survival following anti-cancer treatment for small cell lung cancer.
Jones GS; Elimian K; Baldwin DR; Hubbard RB; McKeever TM
Lung Cancer; 2020 Mar; 141():44-55. PubMed ID: 31955000
[TBL] [Abstract][Full Text] [Related]
11. Dose-intense therapy with etoposide, ifosfamide, cisplatin, and epirubicin (VIP-E) in 100 consecutive patients with limited- and extensive-disease small-cell lung cancer.
Fetscher S; Brugger W; Engelhardt R; Kanz L; Hasse J; Frommhold H; Wenger M; Lange W; Mertelsmann R
Ann Oncol; 1997 Jan; 8(1):49-56. PubMed ID: 9093707
[TBL] [Abstract][Full Text] [Related]
12. High Systemic Immune-Inflammation Index (SII) Represents an Unfavorable Prognostic Factor for Small Cell Lung Cancer Treated with Etoposide and Platinum-Based Chemotherapy.
Wang C; Jin S; Xu S; Cao S
Lung; 2020 Apr; 198(2):405-414. PubMed ID: 32016563
[TBL] [Abstract][Full Text] [Related]
13. Outcomes of Platinum-Sensitive Small-Cell Lung Cancer Patients Treated With Platinum/Etoposide Rechallenge: A Multi-Institutional Retrospective Analysis.
Genestreti G; Tiseo M; Kenmotsu H; Kazushige W; Di Battista M; Cavallo G; Carloni F; Bongiovanni A; Burgio MA; Casanova C; Metro G; Scarpi E; Korkmaz T; Selcuk S; Roopa K; Califano R
Clin Lung Cancer; 2015 Nov; 16(6):e223-8. PubMed ID: 25983005
[TBL] [Abstract][Full Text] [Related]
14. Value of pretreatment serum lactate dehydrogenase as a prognostic and predictive factor for small-cell lung cancer patients treated with first-line platinum-containing chemotherapy.
He M; Chi X; Shi X; Sun Y; Yang X; Wang L; Wang B; Li H
Thorac Cancer; 2021 Dec; 12(23):3101-3109. PubMed ID: 34725930
[TBL] [Abstract][Full Text] [Related]
15. Dose Modification of Etoposide plus Platinum in Elderly Patients with Extensive-Disease Small-Cell Lung Cancer.
Kim H; Choi E; Heo MH; Kim JY; Park KU
Oncology; 2022; 100(6):313-319. PubMed ID: 35390786
[TBL] [Abstract][Full Text] [Related]
16. Efficacy and risk of cytotoxic chemotherapy in extensive disease-small cell lung cancer patients with interstitial pneumonia.
Shirasawa M; Fukui T; Kusuhara S; Hiyoshi Y; Nakahara Y; Nishinarita N; Igawa S; Naoki K
BMC Cancer; 2019 Feb; 19(1):163. PubMed ID: 30808322
[TBL] [Abstract][Full Text] [Related]
17. [Efficacy of adriamycin, etoposide plus ifosfamide on small cell lung cancer--a retrospective analysis of 69 cases treated in Centre Hospitalo-Universitaire de Bordeaux].
Su Y
Ai Zheng; 2006 Dec; 25(12):1569-72. PubMed ID: 17166389
[TBL] [Abstract][Full Text] [Related]
18. The role of integrated 18F-FDG PET-CT as a staging tool for limited-stage small cell lung cancer: a retrospective study.
Sohn BS; Lee DH; Kim EK; Yoon DH; Kim HO; Ryu JS; Kim SW; Suh C
Onkologie; 2012; 35(7-8):432-8. PubMed ID: 22846975
[TBL] [Abstract][Full Text] [Related]
19. Consolidation radiotherapy for patients with extended disease small cell lung cancer in a single tertiary institution: impact of dose and perspectives in the era of immunotherapy.
Stanic K; Vrankar M; But-Hadzic J
Radiol Oncol; 2020 Jul; 54(3):353-363. PubMed ID: 32726294
[TBL] [Abstract][Full Text] [Related]
20. Hypoxia-inducible factor-1α and excision repair cross-complementing 1 in patients with small cell lung cancer who received front-line platinum-based chemotherapy: a retrospective study.
Lee GW; Go SI; Cho YJ; Jeong YY; Kim HC; Duk Lee J; Hwang YS; Ko GH; Lee JH; Kim DC; Yang JW; Oh S; Lee JS
J Thorac Oncol; 2012 Mar; 7(3):528-34. PubMed ID: 22258474
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]